Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arcutis Biotherapeutics, Inc. ARQT

Full chart Compare
Set alert

Price alert · ARQT

All alert types
25.46 USD -1.54 (-5.70%)

Nov 6, 2026, 3:17 PM EST

25.31 Day range 26.22
19.30 52-week range 34.80
YTD
-12.33%
1 year
+1.43%

Financial health

Altman Z-Score

6.10 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -223×
FY 2017: -4.6×FY 2018: -41.1×FY 2019: -19.8×FY 2020: -7.4×FY 2021: -5.0×FY 2022: -2.6×FY 2023: -0.9×FY 2024: -12.0×FY 2025: -223×
FY 2017 5y median -5.0× FY 2025
P/S 9.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 221×FY 2023: 3.8×FY 2024: 8.6×FY 2025: 9.8×
FY 2017 5y median 8.6× FY 2025
P/B 19.5×
FY 2017: -4.6×FY 2018: -32.9×FY 2019: 8.2×FY 2020: 3.7×FY 2021: 3.4×FY 2022: 3.9×FY 2023: 2.5×FY 2024: 10.7×FY 2025: 19.5×
FY 2017 5y median 3.9× FY 2025
P/FCF -585×
FY 2017: -6.1×FY 2018: -56.1×FY 2019: -19.3×FY 2020: -8.9×FY 2021: -5.8×FY 2022: -2.9×FY 2023: -0.9×FY 2024: -15.0×FY 2025: -585×
FY 2017 5y median -5.8× FY 2025
EV/EBITDA 2055×
FY 2017: -23.6×FY 2018: 1564×FY 2019: -18.4×FY 2020: -7.0×FY 2021: -4.9×FY 2022: -3.3×FY 2023: -1.5×FY 2024: -15.7×FY 2025: 2055×
FY 2017 5y median -3.3× FY 2025
EV/Sales 9.7×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 261×FY 2023: 5.7×FY 2024: 8.8×FY 2025: 9.7×
FY 2017 5y median 8.8× FY 2025
FCF Yield -0.2%
FY 2017: -16.4%FY 2018: -1.8%FY 2019: -5.2%FY 2020: -11.3%FY 2021: -17.1%FY 2022: -34.5%FY 2023: -110.6%FY 2024: -6.7%FY 2025: -0.2%
FY 2017 5y median -17.1% FY 2025

Profitability

Gross Margin 90.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 79.5%FY 2023: 91.6%FY 2024: 90.3%FY 2025: 90.2%
FY 2017 5y median 90.2% FY 2025
Operating Margin -3.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -8183.0%FY 2023: -404.5%FY 2024: -65.3%FY 2025: -3.3%
FY 2017 5y median -65.3% FY 2025
Net Margin -4.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -8449.8%FY 2023: -439.8%FY 2024: -71.3%FY 2025: -4.3%
FY 2017 5y median -71.3% FY 2025
ROE -8.5%
FY 2017: 99.7%FY 2018: 80.3%FY 2019: -41.4%FY 2020: -50.1%FY 2021: -69.3%FY 2022: -148.6%FY 2023: -295.6%FY 2024: -88.9%FY 2025: -8.5%
FY 2017 5y median -88.9% FY 2025
ROIC -4.0%
FY 2017: -131.3%FY 2018: -40.8%FY 2019: -42.3%FY 2020: -49.6%FY 2021: -55.0%FY 2022: -73.2%FY 2023: -81.6%FY 2024: -47.8%FY 2025: -4.0%
FY 2017 5y median -55.0% FY 2025
ROA -3.7%
FY 2017: -130.3%FY 2018: -37.7%FY 2019: -39.2%FY 2020: -45.5%FY 2021: -50.6%FY 2022: -69.3%FY 2023: -76.8%FY 2024: -40.1%FY 2025: -3.7%
FY 2017 5y median -50.6% FY 2025

Growth (YoY)

Revenue 91.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 1517.1%FY 2024: 229.7%FY 2025: 91.3%
FY 2017 FY 2025
Operating Income 90.5%
FY 2017: 0.0%FY 2018: -380.6%FY 2019: -118.6%FY 2020: -216.8%FY 2021: -51.1%FY 2022: -46.0%FY 2023: 20.1%FY 2024: 46.7%FY 2025: 90.5%
FY 2017 FY 2025
EPS (diluted) 88.8%
FY 2017: 0.0%FY 2018: 88.7%FY 2019: -107.5%FY 2020: -245.5%FY 2021: -9.7%FY 2022: -35.7%FY 2023: 33.2%FY 2024: 69.3%FY 2025: 88.8%
FY 2017 FY 2025
Free Cash Flow 94.4%
FY 2017: 0.0%FY 2018: -273.1%FY 2019: -206.2%FY 2020: -162.8%FY 2021: -54.9%FY 2022: -60.0%FY 2023: 11.9%FY 2024: 54.6%FY 2025: 94.4%
FY 2017 FY 2025

Financial Health

Current Ratio 3.2×
FY 2017: 5.5×FY 2018: 19.1×FY 2019: 20.3×FY 2020: 13.0×FY 2021: 12.1×FY 2022: 11.6×FY 2023: 7.1×FY 2024: 4.1×FY 2025: 3.2×
FY 2017 5y median 7.1× FY 2025
Quick Ratio 3.0×
FY 2017: 5.5×FY 2018: 19.1×FY 2019: 20.3×FY 2020: 13.0×FY 2021: 12.1×FY 2022: 11.4×FY 2023: 6.8×FY 2024: 4.0×FY 2025: 3.0×
FY 2017 5y median 6.8× FY 2025
Debt / Equity 0.0×
FY 2017: -0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 1.0×FY 2023: 2.3×FY 2024: 0.7×FY 2025: 0.0×
FY 2017 5y median 0.7× FY 2025
Net Debt / EBITDA -20.6×
FY 2017: 2.8×FY 2018: -82.1×FY 2019: 1.5×FY 2020: 0.4×FY 2021: 0.1×FY 2022: -0.5×FY 2023: -0.5×FY 2024: -0.4×FY 2025: -20.6×
FY 2017 5y median -0.5× FY 2025
Interest Coverage -1.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -19.3×FY 2023: -8.1×FY 2024: -4.7×FY 2025: -1.0×
FY 2017 5y median -4.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31